Shanghai Pediatric Cataract Study

NCT03063216 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-09-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of pediatric cataract participants, including congenital and traumatic cataract. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of pediatric cataract.

Conditions

  • Pediatric Cataract
  • Congenital Cataract
  • Traumatic Cataract
  • Visual Outcome
  • Genetic Anticipation

Interventions

PROCEDURE

intraocular lens implantation

1)Pediatric cataract patients with intraocular lens implantation and those without intraocular lens implantation;2)Traumatic cataract patients with intraocular lens implantation and those without intraocular lens implantation

Sponsors & Collaborators

  • Eye & ENT Hospital of Fudan University

    collaborator OTHER
  • Evidence Based Cataract Study Group

    lead OTHER

Principal Investigators

  • Yi Lu, M.D. · Eye and ENT Hospital of Fudan University

  • Xiangjia Zhu, M.D. · Eye and ENT Hospital of Fudan University

  • Keke Zhang, M.D. · Eye and ENT Hospital of Fudan University

  • Wenwen He, M.D. · Eye and ENT Hospital of Fudan University

  • Yu Du, M.D. · Eye and ENT Hospital of Fudan University

  • Yinglei Zhang, M.D. · Eye and ENT Hospital of Fudan University

  • Ruiqi Chang, M.D. · Eye and ENT Hospital of Fudan University

Eligibility

Min Age
2 Months
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2035-12-31
Completion
2045-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063216 on ClinicalTrials.gov